In taking the editorship of the JBC, I join a team committed to the future of our journal. The team happily includes Fred Guengerich as Deputy Editor. Fred has shepherded the JBC over the past year as Interim Editor-in-Chief and prior to that served the journal for many years as Deputy Editor, Associate Editor, and editorial board member. He cares deeply about the journal and knows its workings inside and out. Herb Tabor continues to devote his time to the JBC, serving as co-Editor. As most of you know, Herb was Editor-in-Chief of the JBC for 40 years and continues to generously provide wise guidance. As Director of Publications for the ASBMB, Nancy Rodnan is a true strength of the JBC. We are delighted to add Catherine Goodman, formerly of Nature Chemical Biology, as our new Scientific Editor, bringing a decade of top-tier scientific editing experience to the team. Please keep an eye out for her representing the journal at conferences and get in touch at cgoodman@asbmb.org, as she is eager to connect with the JBC scientific community. And of course, the Associate Editors are active scientists who act as guardians of the quality of the JBC and as shapers of its vision. They work with the editorial board to ensure the rigor of the science in the JBC through a thorough and transparent review process.
This team is now asking what the future holds in store for the JBC. The fundamental premise underlying our strategic planning is that we can enhance the JBC experience for readers and authors while maintaining its strengths. You are invited to join this discussion and offer input on what makes the JBC a journal of choice for publishing top-notch work in mechanistic biochemistry, what draws you to read and cite the JBC, and what the JBC could do better.
In the meantime, you will see that we already have begun implementing changes-some quite significant, and some seemingly minor, but all responsive to feedback we've gathered and geared to enhancing the author and reader experience! • In April, JBC unveiled a completely redesigned website to simplify navigation and improve readability.
• The journal has removed formatting requirements to speed up initial submissions. • Authors will soon be able to seamlessly submit manuscripts posted to bioRxiv to JBC.
• Authors will soon have the option of submitting their manuscripts in LaTex.
• Additional staff at the JBC will assist authors as their papers move toward publication, improve readability of the journal, and ensure that critical requirements are met, such as data deposition in appropriate community databases. • The JBC now welcomes Methods and Resources papers that describe new technical advances and large data sets.
• We encourage authors to submit their work as Accelerated Communications (replacing Reports), a return to an old manuscript type but with three important changes. The figure restrictions are now relaxed, such that authors can choose the optimal balance between words and imagery. Supplemental Data are allowed in Accelerated Communications. And, finally, the timeline for review of Accelerated Communications is even faster than the JBC's 21-day average time from submission to first decision: Reviewers are asked to complete their reviews of Accelerated Communications in just five days. We're excited about these changes, and we're still in the midst of reviewing basic journal policies and practices to identify and revise any that present obstacles or disincentives to potential authors. However, we know that the challenges and opportunities in scientific publishing in 2016 go beyond technological and formatting issues. We're using this period of introspection under new leadership as an opportunity to think creatively about the future of scientific publishing, building on the JBC's strong tradition of innovation, and reaffirming the JBC's commitment to peer review and a shared goal of promoting research that reveals the molecular mechanisms of biological processes.
We welcome your thoughts on these issues at feedback@asbmb.org. And keep watching this space for more updates!
